查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1933332

全球正子断层扫描 (PET) 市场：市场规模、占有率、成长率、产业分析、依类型、应用和地区划分的分析以及预测 (2026-2034)

Positron Emission Tomography Scan Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 200 Pages | 商品交期: 请询问到货日

价格

正子断层扫描 (PET) 市场成长驱动因素

由于慢性病发病率上升、对早期精准诊断的需求不断增长以及成像技术的持续进步，全球正电子发射断层扫描 (PET) 市场正经历稳步增长。 正子断层扫描（PET）是一种核医学影像技术，能够可视化体内代谢和生理活动，在肿瘤学、心臟病学和神经病学领域应用广泛。

2025年全球PET扫描市场规模为187.1亿美元。预计该市场将从2026年的194.6亿美元成长到2034年的296.7亿美元，预测期内（2026-2034年）复合年增长率（CAGR）为5.41%。北美地区凭藉先进的医疗基础设施、完善的报销体係以及混合成像系统的广泛应用，在2025年占全球市场主导地位，市场占有率高达52.38%。

新冠疫情的影响

由于封锁措施以及择期和非紧急影像检查的延迟，新冠疫情对PET扫描市场造成了负面影响。包括PET扫描在内的核子医学服务在2020年经历了检查数量的下降。然而，自2021年以来，诊断服务的恢復和患者预后的改善推动了市场的復苏。 PET影像在肿瘤学和神经病学领域日益增长的重要性将使市场重获动力，并在预测期内保持稳定成长。

市场趋势

混合影像系统日益普及

影响PET扫描市场的关键趋势之一是混合影像系统（例如PET/CT和PET/MRI）的日益普及。这些系统结合了功能性影像和解剖成像，以提高诊断准确性、治疗计划制定和疾病监测。 欧洲核子医学协会 (EANM) 于 2023 年发布的指南进一步支持将 PET/MRI 整合到常规临床实践中。

放射性示踪剂研发与人工智慧整合的进展

放射性追踪剂研发的持续进展正在改善癌症、神经系统疾病和心血管疾病的检测和监测。此外，人工智慧 (AI) 和机器学习的整合正在增强影像重建、缩短扫描时间并提高工作流程效率，从而提高医疗机构对 PET 扫描的采用率。

市场成长驱动因素

慢性病发生率上升

癌症、神经系统疾病和心血管疾病发生率的上升是推动 PET 检测需求的主要驱动因素。 PET 影像在早期检测、分期和治疗追踪中发挥关键作用。根据世界卫生组织估计，帕金森氏症和阿兹海默症等神经系统疾病在全球范围内持续增加，推动了对先进诊断影像检测的需求。

对早期精准诊断的需求日益增长

政府措施、不断增长的医疗保健支出以及对诊断基础设施的投资正在推动对早期精准诊断工具的需求。 PET扫描具有高灵敏度和特异性，使其成为现代诊断流程的重要组成部分。

限制因子

儘管成长前景良好，但市场仍面临诸多挑战，例如设备和检测成本高昂、放射性药物供应有限以及新兴国家保险覆盖范围有限。此外，能够操作先进影像诊断系统的熟练专业人员短缺仍然是一个主要限制因素，尤其是在发展中地区。

细分市场分析

依适应症划分

肿瘤学领域预计将在2026年占66.93%的市场占有率，这主要得益于全球癌症负担的加重以及PET扫描在诊断和治疗随访中日益广泛的应用。 由于神经系统疾病和心血管疾病的盛行率不断上升，神经病学和心臟病学领域也占了相当大的占有率。

依资金来源划分

到2026年，公共医疗保险领域占了84.26%的显着占有率，这主要得益于政府对医疗保健的投入以及已开发国家扩大PET成像程序的报销范围。

依服务提供者划分

到2026年，医院以65.34%的市占率领先。这得归功于先进的基础设施、庞大的患者数量以及混合成像系统的普及。 由于独立影像设施的增加，诊断中心预计将保持稳定成长。

区域概览

  • 北美：预计到 2026 年，市场规模将达到 102 亿美元，其中美国市场预计到 2026 年将达到 101.1 亿美元。
  • 欧洲：慢性病盛行率的上升和 PET 扫描仪安装量的增加推动了市场成长。
  • 亚太地区：由于医疗保健投资和人口老化，该地区预计将实现最高的复合年增长率。
  • 拉丁美洲、中东和非洲：由于保险覆盖范围有限和基础设施不发达，预计成长速度将放缓。

主要公司

主要公司包括 RadNet, Inc.、Sonic Healthcare Limited、Akumin Inc.、Alliance Medical Limited、Apex Radiology、InHealth Group 和 Novant Health。 策略联盟、人工智慧整合以及影像诊断网路扩展将继续是关键的竞争策略。

目录

第一章：引言

第二章：摘要整理

第三章：市场动态

  • 市场驱动因素
  • 市场限制因素
  • 市场机遇
  • 市场趋势

第四章：关键考虑因素

  • 主要国家/地区 PET 扫描量（2025 年）
  • 主要国家的监管状况
  • 主要产业发展动态（併购、合作、新产品发表等）
  • 新冠疫情的影响市场

第五章 全球正子断层扫描 (PET) 市场分析：洞察与预测 (2021-2034)

  • 市场分析、洞察与预测：依适应症划分
    • 肿瘤科
    • 心臟科
    • 神经科
    • 其他
  • 市场分析、洞察与预测：依资金来源划分
    • 公共医疗保险
    • 私人医疗保险/自费
  • 市场分析、洞察与预测：依服务提供者划分
    • 医院
    • 诊断中心
    • 其他
  • 市场分析、洞察与预测：依地区划分
    • 北美美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲

第六章 北美正子断层扫描 (PET) 市场分析：洞察与预测 (2021-2034)

  • 依国家划分
    • 美国
    • 加拿大

第七章：欧洲正子断层扫描 (PET) 市场分析：洞察与预测 (2021-2034)

  • 依国家划分
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 斯堪的纳维亚
    • 欧洲其他地区

章节第八章 亚太地区正子断层扫描 (PET) 市场分析：洞察与预测 (2021-2034)

  • 依国家划分
    • 日本
    • 中国
    • 印度
    • 澳大利亚
    • 东南亚
    • 亚太其他地区

第九章 拉丁美洲正子断层扫描 (PET) 市场分析：洞察与预测 (2021-2034)

  • 依国家划分
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地区

第十章 中东与非洲正子断层扫描 (PET) 市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 海湾合作委员会 (GCC) 国家
    • 南非
    • 中东和非洲其他地区

第十一章 竞争分析

  • 全球市占率分析（2025）
  • 公司简介
  • RadNet, Inc.
  • Sonic Healthcare Limited
  • Akumin Inc.
  • Apex Radiology
  • Alliance Medical Limited
  • Novant Health
  • InHealth Group
  • Dignity Health
  • Concord Medical
Product Code: FBI111805

Growth Factors of positron emission tomography (PET) scan Market

The global positron emission tomography (PET) scan market is witnessing steady growth due to the increasing burden of chronic diseases, rising demand for early and accurate diagnostics, and continuous advancements in imaging technologies. Positron emission tomography is a nuclear imaging technique that enables visualization of metabolic and physiological activities within the body, making it highly valuable for oncology, cardiology, and neurology applications.

In 2025, the global PET scan market size was valued at USD 18.71 billion. The market is projected to grow from USD 19.46 billion in 2026 to USD 29.67 billion by 2034, registering a CAGR of 5.41% during the forecast period (2026-2034). North America dominated the global market with a 52.38% market share in 2025, supported by advanced healthcare infrastructure, strong reimbursement frameworks, and widespread adoption of hybrid imaging systems.

COVID-19 Impact

The COVID-19 pandemic had a negative impact on the PET scan market due to lockdowns and the postponement of elective and non-emergency imaging procedures. Nuclear medicine services, including PET scans, experienced a decline in procedure volumes during 2020. However, since 2021, the resumption of diagnostic services and improved patient outcomes have supported market recovery. The growing importance of PET imaging in oncology and neurology has enabled the market to regain momentum and maintain steady growth during the forecast period.

Market Trends

Increasing Adoption of Hybrid Imaging Systems

One of the key trends shaping the PET scan market is the growing adoption of hybrid imaging systems such as PET/CT and PET/MRI. These systems combine functional and anatomical imaging, enhancing diagnostic accuracy, treatment planning, and disease monitoring. Guidelines published by the European Association of Nuclear Medicine (EANM) in 2023 have further supported the integration of PET/MRI into routine clinical practice.

Advancements in Radiotracer Development and AI Integration

Continuous advancements in radiotracer development are improving the detection and monitoring of cancers, neurological, and cardiovascular disorders. Additionally, the integration of artificial intelligence and machine learning is enhancing image reconstruction, reducing scan time, and improving workflow efficiency, thereby increasing PET scan adoption across healthcare facilities.

Market Growth Drivers

Rising Prevalence of Chronic Diseases

The rising incidence of cancer, neurological disorders, and cardiovascular diseases is a major driver of PET scan demand. PET imaging plays a critical role in early detection, disease staging, and treatment monitoring. According to WHO estimates, neurological disorders such as Parkinson's disease and Alzheimer's disease continue to rise globally, boosting demand for advanced diagnostic imaging.

Growing Demand for Early and Accurate Diagnosis

Government initiatives, increased healthcare spending, and investments in diagnostic infrastructure are driving demand for early and precise diagnostic tools. PET scans provide high sensitivity and specificity, making them an essential component of modern diagnostic pathways.

Restraining Factors

Despite favorable growth prospects, the market faces challenges due to high equipment and procedure costs, limited availability of radiopharmaceuticals, and restricted reimbursement policies in emerging countries. Additionally, the shortage of skilled professionals capable of operating advanced imaging systems remains a key constraint, particularly in developing regions.

Segmentation Analysis

By Indication

The oncology segment dominated the market with a 66.93% share in 2026, driven by the rising global cancer burden and increasing use of PET scans for diagnosis and treatment monitoring. Neurology and cardiology segments also hold significant shares due to increasing prevalence of neurological and cardiovascular disorders.

By Source of Payment

The public reimbursement segment accounted for a major share of 84.26% in 2026, supported by government healthcare funding and expanded reimbursement for PET imaging procedures in developed economies.

By Service Provider

Hospitals led the market with a 65.34% share in 2026, owing to advanced infrastructure, high patient volumes, and availability of hybrid imaging systems. Diagnostic centers are expected to witness steady growth due to increasing standalone imaging facilities.

Regional Insights

  • North America: Generated USD 10.2 billion in 2026, with the U.S. market projected to reach USD 10.11 billion by 2026
  • Europe: Growth supported by rising chronic disease prevalence and expanding PET scanner installations
  • Asia Pacific: Expected to register the highest CAGR due to healthcare investments and aging population
  • Latin America & Middle East & Africa: Moderate growth due to limited reimbursement and infrastructure

Key Industry Players

Major players include RadNet, Inc., Sonic Healthcare Limited, Akumin Inc., Alliance Medical Limited, Apex Radiology, InHealth Group, and Novant Health. Strategic partnerships, AI integration, and expansion of imaging networks remain key competitive strategies.

Conclusion

The global positron emission tomography (PET) scan market is set for steady expansion, growing from USD 18.71 billion in 2025 to USD 29.67 billion by 2034. Rising prevalence of chronic diseases, increasing demand for early and accurate diagnostics, and technological advancements such as hybrid imaging and artificial intelligence are driving market growth. Although high costs, reimbursement limitations, and workforce shortages pose challenges, continued investments in healthcare infrastructure and innovation are expected to support sustained market development over the forecast period.

Segmentation By Indication,Source of Payment, Service Provider, and Region

By Indication * Oncology

  • Cardiology
  • Neurology
  • Others

By Source of Payment * Public

  • Private Health Insurance/Out-of-pocket

By Service Provider * Hospitals

  • Diagnostic Centers
  • Others

By Region * North America (By Indication, By Source of Payment, By Service Provider, By Country)

    • U.S.
    • Canada
  • Europe (By Indication, By Source of Payment, By Service Provider, By Country/Sub-Region)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Indication, By Source of Payment, By Service Provider, By Country/Sub-Region)
    • Japan
    • China
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Indication, By Source of Payment, By Service Provider, By Country/Sub-Region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Indication, By Source of Payment, By Service Providers, By Country/Sub-Region)
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Number of PET Scans, Key Countries/ Region, 2025
  • 4.2. Regulatory Scenario, By Key Countries/ Region
  • 4.3. Key Industry Developments (Mergers, Acquisitions, Partnerships, Launches, etc.)
  • 4.4. Impact of COVID-19 in the Market

5. Global Positron Emission Tomography Scan Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Indication
    • 5.1.1. Oncology
    • 5.1.2. Cardiology
    • 5.1.3. Neurology
    • 5.1.4. Others
  • 5.2. Market Analysis, Insights and Forecast - By Source of Payment
    • 5.2.1. Public
    • 5.2.2. Private Health Insurance/Out-of-pocket
  • 5.3. Market Analysis, Insights and Forecast - By Service Provider
    • 5.3.1. Hospitals
    • 5.3.2. Diagnostic Centers
    • 5.3.3. Others
  • 5.4. Market Analysis, Insights and Forecast - By Region
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. Asia Pacific
    • 5.4.4. Latin America
    • 5.4.5. Middle East & Africa

6. North America Positron Emission Tomography Scan Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Indication
    • 6.1.1. Oncology
    • 6.1.2. Cardiology
    • 6.1.3. Neurology
    • 6.1.4. Others
  • 6.2. Market Analysis, Insights and Forecast - By Source of Payment
    • 6.2.1. Public
    • 6.2.2. Private Health Insurance/Out-of-pocket
  • 6.3. Market Analysis, Insights and Forecast - By Service Provider
    • 6.3.1. Hospitals
    • 6.3.2. Diagnostic Centers
    • 6.3.3. Others
  • 6.4. Market Analysis, Insights and Forecast - By Country
    • 6.4.1. U.S.
    • 6.4.2. Canada

7. Europe Positron Emission Tomography Scan Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Indication
    • 7.1.1. Oncology
    • 7.1.2. Cardiology
    • 7.1.3. Neurology
    • 7.1.4. Others
  • 7.2. Market Analysis, Insights and Forecast - By Source of Payment
    • 7.2.1. Public
    • 7.2.2. Private Health Insurance/Out-of-pocket
  • 7.3. Market Analysis, Insights and Forecast - By Service Provider
    • 7.3.1. Hospitals
    • 7.3.2. Diagnostic Centers
    • 7.3.3. Others
  • 7.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 7.4.1. Germany
    • 7.4.2. U.K.
    • 7.4.3. France
    • 7.4.4. Spain
    • 7.4.5. Italy
    • 7.4.6. Scandinavia
    • 7.4.7. Rest of Europe

8. Asia Pacific Positron Emission Tomography Scan Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Indication
    • 8.1.1. Oncology
    • 8.1.2. Cardiology
    • 8.1.3. Neurology
    • 8.1.4. Others
  • 8.2. Market Analysis, Insights and Forecast - By Source of Payment
    • 8.2.1. Public
    • 8.2.2. Private Health Insurance/Out-of-pocket
  • 8.3. Market Analysis, Insights and Forecast - By Service Provider
    • 8.3.1. Hospitals
    • 8.3.2. Diagnostic Centers
    • 8.3.3. Others
  • 8.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 8.4.1. Japan
    • 8.4.2. China
    • 8.4.3. India
    • 8.4.4. Australia
    • 8.4.5. Southeast Asia
    • 8.4.6. Rest of Asia Pacific

9. Latin America Positron Emission Tomography Scan Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Indication
    • 9.1.1. Oncology
    • 9.1.2. Cardiology
    • 9.1.3. Neurology
    • 9.1.4. Others
  • 9.2. Market Analysis, Insights and Forecast - By Source of Payment
    • 9.2.1. Public
    • 9.2.2. Private Health Insurance/Out-of-pocket
  • 9.3. Market Analysis, Insights and Forecast - By Service Provider
    • 9.3.1. Hospitals
    • 9.3.2. Diagnostic Centers
    • 9.3.3. Others
  • 9.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 9.4.1. Brazil
    • 9.4.2. Mexico
    • 9.4.3. Rest of Latin America

10. Middle East & Africa Positron Emission Tomography Scan Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Indication
    • 10.1.1. Oncology
    • 10.1.2. Cardiology
    • 10.1.3. Neurology
    • 10.1.4. Others
  • 10.2. Market Analysis, Insights and Forecast - By Source of Payment
    • 10.2.1. Public
    • 10.2.2. Private Health Insurance/Out-of-pocket
  • 10.3. Market Analysis, Insights and Forecast - By Service Provider
    • 10.3.1. Hospitals
    • 10.3.2. Diagnostic Centers
    • 10.3.3. Others
  • 10.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 10.4.1. GCC
    • 10.4.2. South Africa
    • 10.4.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles (Overview, Services, SWOT Analysis, Recent Developments, Strategies, financials (Based on Availability))
    • 11.2.1. RadNet, Inc.
    • 11.2.2. Sonic Healthcare Limited
    • 11.2.3. Akumin Inc.
    • 11.2.4. Apex Radiology
    • 11.2.5. Alliance Medical Limited
    • 11.2.6. Novant Health
    • 11.2.7. InHealth Group
    • 11.2.8. Dignity Health
    • 11.2.9. Concord Medical

List of Tables

  • Table 1: Global Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, By Indication, 2021-2034
  • Table 2: Global Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, By Source of Payment, 2021-2034
  • Table 3: Global Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, By Service Provider, 2021-2034
  • Table 4: Global Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, By Region, 2021-2034
  • Table 5: North America Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, By Indication, 2021-2034
  • Table 6: North America Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, By Source of Payment, 2021-2034
  • Table 7: North America Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, By Service Provider, 2021-2034
  • Table 8: North America Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 9: Europe Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, By Indication, 2021-2034
  • Table 10: Europe Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, By Source of Payment, 2021-2034
  • Table 11: Europe Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, By Service Provider, 2021-2034
  • Table 12: Europe Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2021-2034
  • Table 13: Asia Pacific Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, By Indication, 2021-2034
  • Table 14: Asia Pacific Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, By Source of Payment, 2021-2034
  • Table 15: Asia Pacific Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, By Service Provider, 2021-2034
  • Table 16: Asia Pacific Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2021-2034
  • Table 17: Latin America Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, By Indication, 2021-2034
  • Table 18: Latin America Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, By Source of Payment, 2021-2034
  • Table 19: Latin America Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, By Service Provider, 2021-2034
  • Table 20: Latin America Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2021-2034
  • Table 21: Middle East & Africa Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, By Indication, 2021-2034
  • Table 22: Middle East & Africa Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, By Source of Payment, 2021-2034
  • Table 23: Middle East & Africa Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, By Service Provider, 2021-2034
  • Table 24: Middle East & Africa Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2021-2034

List of Figures

  • Figure 1: Global Positron Emission Tomography Scan Market Revenue Breakdown (USD billion, %), By Region, 2025 & 2034
  • Figure 2: Global Positron Emission Tomography Scan Market Value Share (%), By Indication, 2025 & 2034
  • Figure 3: Global Positron Emission Tomography Scan Market Value Share (%), By Source of Payment, 2025 & 2034
  • Figure 4: Global Positron Emission Tomography Scan Market Value Share (%), By Service Provider, 2025 & 2034
  • Figure 5: Global Positron Emission Tomography Scan Market Value Share (%), By Region, 2025 & 2034
  • Figure 6: North America Positron Emission Tomography Scan Market Value (USD billion), By Indication, 2025 & 2034
  • Figure 7: North America Positron Emission Tomography Scan Market Value Share (%), By Indication, 2025
  • Figure 8: North America Positron Emission Tomography Scan Market Value (USD billion), By Source of Payment, 2025 & 2034
  • Figure 9: North America Positron Emission Tomography Scan Market Value Share (%), By Source of Payment, 2025
  • Figure 10: North America Positron Emission Tomography Scan Market Value (USD billion), By Service Provider, 2025 & 2034
  • Figure 11: North America Positron Emission Tomography Scan Market Value Share (%), By Service Provider, 2025
  • Figure 12: North America Positron Emission Tomography Scan Market Value (USD billion), By Country, 2025 & 2034
  • Figure 13: North America Positron Emission Tomography Scan Market Value Share (%), By Country, 2025
  • Figure 14: Europe Positron Emission Tomography Scan Market Value (USD billion), By Indication, 2025 & 2034
  • Figure 15: Europe Positron Emission Tomography Scan Market Value Share (%), By Indication, 2025
  • Figure 16: Europe Positron Emission Tomography Scan Market Value (USD billion), By Source of Payment, 2025 & 2034
  • Figure 17: Europe Positron Emission Tomography Scan Market Value Share (%), By Source of Payment, 2025
  • Figure 18: Europe Positron Emission Tomography Scan Market Value (USD billion), By Service Provider, 2025 & 2034
  • Figure 19: Europe Positron Emission Tomography Scan Market Value Share (%), By Service Provider, 2025
  • Figure 20: Europe Positron Emission Tomography Scan Market Value (USD billion), By Country/Sub-Region, 2025 & 2034
  • Figure 21: Europe Positron Emission Tomography Scan Market Value Share (%), By Country/Sub-Region, 2025
  • Figure 22: Asia Pacific Positron Emission Tomography Scan Market Value (USD billion), By Indication, 2025 & 2034
  • Figure 23: Asia Pacific Positron Emission Tomography Scan Market Value Share (%), By Indication, 2025
  • Figure 24: Asia Pacific Positron Emission Tomography Scan Market Value (USD billion), By Source of Payment, 2025 & 2034
  • Figure 25: Asia Pacific Positron Emission Tomography Scan Market Value Share (%), By Source of Payment, 2025
  • Figure 26: Asia Pacific Positron Emission Tomography Scan Market Value (USD billion), By Service Provider, 2025 & 2034
  • Figure 27: Asia Pacific Positron Emission Tomography Scan Market Value Share (%), By Service Provider, 2025
  • Figure 28: Asia Pacific Positron Emission Tomography Scan Market Value (USD billion), By Country/Sub-Region, 2025 & 2034
  • Figure 29: Asia Pacific Positron Emission Tomography Scan Market Value Share (%), By Country/Sub-Region, 2025
  • Figure 30: Latin America Positron Emission Tomography Scan Market Value (USD billion), By Indication, 2025 & 2034
  • Figure 31: Latin America Positron Emission Tomography Scan Market Value Share (%), By Indication, 2025
  • Figure 32: Latin America Positron Emission Tomography Scan Market Value (USD billion), By Source of Payment, 2025 & 2034
  • Figure 33: Latin America Positron Emission Tomography Scan Market Value Share (%), By Source of Payment, 2025
  • Figure 34: Latin America Positron Emission Tomography Scan Market Value (USD billion), By Service Provider, 2025 & 2034
  • Figure 35: Latin America Positron Emission Tomography Scan Market Value Share (%), By Service Provider, 2025
  • Figure 36: Latin America Positron Emission Tomography Scan Market Value (USD billion), By Country/Sub-Region, 2025 & 2034
  • Figure 37: Latin America Positron Emission Tomography Scan Market Value Share (%), By Country/Sub-Region, 2025
  • Figure 38: Middle East & Africa Positron Emission Tomography Scan Market Value (USD billion), By Indication, 2025 & 2034
  • Figure 39: Middle East & Africa Positron Emission Tomography Scan Market Value Share (%), By Indication, 2025
  • Figure 40: Middle East & Africa Positron Emission Tomography Scan Market Value (USD billion), By Source of Payment, 2025 & 2034
  • Figure 41: Middle East & Africa Positron Emission Tomography Scan Market Value Share (%), By Source of Payment, 2025
  • Figure 42: Middle East & Africa Positron Emission Tomography Scan Market Value (USD billion), By Service Provider, 2025 & 2034
  • Figure 43: Middle East & Africa Positron Emission Tomography Scan Market Value Share (%), By Service Provider, 2025
  • Figure 44: Middle East & Africa Positron Emission Tomography Scan Market Value (USD billion), By Country/Sub-Region, 2025 & 2034
  • Figure 45: Middle East & Africa Positron Emission Tomography Scan Market Value Share (%), By Country/Sub-Region, 2025
  • Figure 46: Global Positron Emission Tomography Scan Market Share (%), 2025